Dr Mart Roosimaa explores the relationship between CV event reduction, GLP-1 RAs and HbA1c. in lowering the reduction of CV risk in T2DM patients.
Recorded remotely from Tartu, Estonia, 2020
Recording Editor: Michael Knight
Video
Published: 20 Nov 2020
Views:
274Likes:
1Dr Mart Roosimaa explores the relationship between CV event reduction, GLP-1 RAs and HbA1c. in lowering the reduction of CV risk in T2DM patients.
Recorded remotely from Tartu, Estonia, 2020
Recording Editor: Michael Knight
This presentation was supported by an unrestricted educational grant from Novo Nordisk